BridgeBio Pharma Income Statement (2017-2026) | BBIO

Income Statement Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
8.50M2.34M10.00M1.69M73.75M0.34M1.87M1.83M1.64M4.09M1.75M211.12M2.17M2.73M5.88M116.63M110.56M120.70M154.18M194.51M
Cost of Revenue (Quarter)
0.11M1.45M1.55M0.70M0.74M0.65M0.65M0.60M0.60M0.60M0.60M0.60M0.60M2.08M2.64M3.65M6.56M8.11M9.94M
Gross Profit (Quarter)
8.39M0.89M8.45M73.05M-0.40M1.22M1.18M1.04M3.49M1.15M210.52M1.57M2.13M3.80M113.99M106.91M114.14M146.07M184.58M
Operating items
Research & Development (Quarter)
101.96M104.31M122.20M107.65M108.40M92.51M90.90M92.86M107.49M125.14M130.23M140.97M114.69M120.44M130.35M111.43M111.23M112.87M116.42M126.64M
Selling, General & Administrative (Quarter)
45.97M46.08M54.75M43.71M36.43M31.19M31.86M31.11M36.12M35.78M47.58M65.81M59.52M68.82M94.78M106.36M129.15M137.62M158.09M163.90M
Restructuring Costs (Quarter)
22.66M8.40M5.02M7.69M3.37M3.53M0.27M0.75M1.16M2.35M4.62M4.69M0.57M0.71M8.84M11.13M
Other Operating Expenses (Quarter)
0.11M1.45M1.55M1.35M0.70M0.74M0.65M0.65M0.60M0.60M0.60M2.83M1.14M0.60M2.08M2.64M3.75M6.56M8.11M9.94M
Operating Expenses (Quarter)
148.04M151.84M178.50M175.37M153.92M129.45M131.10M127.99M147.74M161.78M179.16M210.78M177.71M194.48M231.91M221.00M244.84M265.90M293.74M300.47M
Operating Income (Quarter)
-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M
EBIT (Quarter)
-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M
Non-operating items
Interest & Investment Income (Quarter)
0.32M0.23M0.18M0.27M0.77M2.42M4.09M4.15M4.51M3.79M5.58M4.08M5.20M3.30M4.68M5.38M3.90M6.24M4.33M6.25M
Other Non Operating Income (Quarter)
2.46M-0.68M28.28M-7.58M-10.82M6.33M4.56M-0.60M-5.28M21.78M9.48M8.23M6.55M11.82M
Non Operating Income (Quarter)
-8.06M-11.52M58.98M-27.65M-10.82M6.33M39.61M-0.60M-14.60M-5.28M70.34M-36.50M-0.63M27.50M40.13M-65.24M-47.38M-41.28M-240.33M4.25M
Net income details
EBT (Quarter)
-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-75.54M-164.25M-266.24M-117.11M-181.66M-186.48M-194.75M-112.65M
Tax Provisions (Quarter)
1.15M2.10M-1.50M-0.12M
Profit After Tax (Quarter)
-102.07M-161.02M-152.28M-201.33M-2.56M-140.19M-140.57M-142.73M-160.70M-179.49M-170.33M-36.16M-75.54M-164.25M-267.39M-169.61M-183.76M-184.94M-194.63M-166.56M
Equity Income (Quarter)
-7.92M-6.56M-8.50M-15.56M-20.19M-15.83M-21.03M-18.28M
Income from Non-Controlling Interests (Quarter)
-5.73M-5.08M-5.11M-4.93M7.30M-2.85M-2.98M-2.58M-2.80M-2.49M-2.18M-0.94M-2.09M-2.21M-2.34M-2.19M-1.85M-2.19M-1.77M-2.51M
Income from Continuing Operations (Quarter)
-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-75.54M-164.25M-267.39M-117.11M-183.76M-184.98M-194.63M-112.65M
Consolidated Net Income (Quarter)
-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-75.54M-164.25M-267.39M-117.11M-183.76M-184.98M-194.63M-112.65M
Income towards Parent Company (Quarter)
-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-75.54M-164.25M-267.39M-117.11M-183.76M-184.98M-194.63M-112.65M
Net Income towards Common Stockholders (Quarter)
-96.35M-155.94M-147.18M-196.40M-9.86M-137.34M-137.59M-140.16M-157.90M-177.00M-168.15M-35.22M-73.46M-162.04M-265.05M-167.42M-181.90M-182.74M-192.86M-164.04M
Additional items
EPS (Basic) (Quarter)
-0.66-1.06-1.02-1.35-0.07-0.93-0.92-0.92-0.98-1.08-0.96-0.20-0.39-0.86-1.42-0.88-0.95-0.95-0.99-0.84
EPS (Weighted Average and Diluted) (Quarter)
-0.66-1.06-1.02-1.35-0.07-0.93-0.92-0.92-0.98-1.08-0.96-0.20-0.39-0.86-1.42-0.88-0.95-0.95-0.99-0.84
Shares Outstanding (Weighted Average) (Quarter)
142.71M144.04M144.36M145.88M146.29M147.94M147.47M152.65M156.65M158.89M162.79M178.71M187.59M184.95M186.08M190.15M190.52M191.85M191.53M194.79M
Shares Outstanding (Diluted Average) (Quarter)
142.71M144.04M144.36M145.88M146.29M147.94M147.47M152.65M160.54M163.31M162.79M178.71M183.15M184.95M186.08M190.15M190.33M191.85M191.53M194.79M
EBITDA (Quarter)
-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M
Interest Expenses (Quarter)
10.84M11.07M15.13M20.34M20.28M19.82M19.99M20.12M20.59M20.31M20.27M23.47M22.94M23.06M21.52M18.12M37.64M11.74M11.64M12.94M
Tax Rate (Quarter)
-0.43%-1.16%0.80%0.06%